Chubb Limited vs Bristol-Myers Squibb Company
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก ๋น๊ต
Chubb Limited
$131.5B
์์ #129
Bristol-Myers Squibb Company
$132.0B
์์ #127
์๊ฐ์ ๋ฐ๋ฅธ ์๊ฐ์ด์ก
์ฃผ์ ์๊ฐ
- Chubb Limited์ด(๊ฐ) 2025๋ ๊น์ง Bristol-Myers Squibb Company์(๋ฅผ) ์ถ์ํ์ต๋๋ค
- Bristol-Myers Squibb Company์ด(๊ฐ) 2026๋ ๊น์ง Chubb Limited์(๋ฅผ) ์ถ์ํ์ต๋๋ค
์ฐ๋๋ณ ๋น๊ต
| ์ฐ๋ | Chubb Limited | Bristol-Myers Squibb Company | ์ ๋ |
|---|---|---|---|
| 2026 | $131.5B | $132.0B | Bristol-Myers Squibb Company |
| 2025 | $120.7B | $107.8B | Chubb Limited |
| 2024 | $105.8B | $107.6B | Bristol-Myers Squibb Company |
| 2023 | $85.4B | $92.9B | Bristol-Myers Squibb Company |
| 2022 | $81.9B | $125.8B | Bristol-Myers Squibb Company |
| 2021 | $70.6B | $105.8B | Bristol-Myers Squibb Company |
| 2020 | $55.2B | $102.0B | Bristol-Myers Squibb Company |
| 2019 | $54.4B | $102.4B | Bristol-Myers Squibb Company |
| 2018 | $44.2B | $80.2B | Bristol-Myers Squibb Company |
| 2017 | $49.0B | $92.0B | Bristol-Myers Squibb Company |
| 2016 | $43.4B | $85.4B | Bristol-Myers Squibb Company |
| 2015 | $37.5B | $98.2B | Bristol-Myers Squibb Company |
| 2014 | $36.0B | $82.3B | Bristol-Myers Squibb Company |
| 2013 | $31.6B | $72.0B | Bristol-Myers Squibb Company |
| 2012 | $23.9B | $42.7B | Bristol-Myers Squibb Company |
| 2011 | $20.4B | $44.4B | Bristol-Myers Squibb Company |
| 2010 | $17.7B | $31.8B | Bristol-Myers Squibb Company |
| 2009 | $14.0B | $28.9B | Bristol-Myers Squibb Company |
| 2008 | $14.4B | $25.1B | Bristol-Myers Squibb Company |
| 2007 | $16.4B | $27.1B | Bristol-Myers Squibb Company |
| 2006 | $15.8B | $25.9B | Bristol-Myers Squibb Company |
| 2005 | $13.7B | $21.6B | Bristol-Myers Squibb Company |
| 2004 | $10.8B | $23.0B | Bristol-Myers Squibb Company |
| 2003 | $10.2B | $24.5B | Bristol-Myers Squibb Company |
| 2002 | $7.1B | $19.0B | Bristol-Myers Squibb Company |
| 2001 | $9.5B | $40.3B | Bristol-Myers Squibb Company |
| 2000 | $9.9B | $54.6B | Bristol-Myers Squibb Company |
| 1999 | $3.8B | $46.6B | Bristol-Myers Squibb Company |
| 1998 | $7.7B | $48.0B | Bristol-Myers Squibb Company |
| 1997 | $7.2B | $33.4B | Bristol-Myers Squibb Company |
| 1996 | $4.4B | $18.8B | Bristol-Myers Squibb Company |
| 1995 | $2.9B | $14.3B | Bristol-Myers Squibb Company |
| 1994 | $1.7B | $9.2B | Bristol-Myers Squibb Company |